Nektar Therapeutics (NKTR) Social Stream

Featured Post From StockTwits About NKTR

$NKTR very bullish call. The new Chief Medical Officer added is an administrative layer to help with registrations and forthcoming approvals that are no doubt expected based on what they are seeing in the data. JZ hinted at how the propel data already shows better results in the two cohorts that standard of care are less effective with. This was his way of foreshadowing the positive data. Anyone meaningfully short this stock was mighty passed by this call, especially when being reminded of the absolute nonstop gravy train of applications above and beyond 214.